Search | Soocian

Rohit More added blog Other
2026-06-16 07:20:27 -

Increasing Demand for Plasma-Derived Therapies and Advances in Immunology Treatments Strengthen Growth Prospects for the Global Immunoglobulins Market
According to the latest report published by Data Bridge Market Research, the Immunoglobulins Market Global immunoglobulins market size was valued at USD 16.06 billion in 2024 and is projected to reach USD 27.69 billion by 2032, with a CAGR of 7.05% during the forecast period of 2025 to 2032. The persuasive Immunoglobulins Market report covers several topics including market trend...

0 Comments 0 Shares 102 Views 0 Reviews

Please log in to like, share and comment!
Surbhi Verma added blog Health
2026-08-06 10:22:11 -

J Chain Antibody Market: Is Growing IgA and IgM Research Demand Driving This Specialized Immunology Segment?
J chain antibody's structural immunology role — the joining chain (J chain) glycoprotein that links immunoglobulin monomers together to form polymeric IgM and secretory IgA antibody complexes, along with the research reagents, diagnostic assays, and therapeutic development tools built around this specific antibody component — represents a specialized but scientifically significant...

0 Comments 0 Shares 8 Views 0 Reviews

Please log in to like, share and comment!
Rohit More added blog Other
2026-06-17 05:24:36 -

Adalimumab Biosimilar Market Accelerates as Cost-Effective Biologic Therapies Expand Access to Autoimmune Disease Treatment
According to the latest report published by Data Bridge Market Research, the Adalimumab Biosimilar Market Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30 million in 2022, is expected to reach USD 3431.48 million by 2030, at a CAGR of 24.4% during the forecast period 2023 to 2030. For generating the Adalimumab Biosimilar...

0 Comments 0 Shares 129 Views 0 Reviews

Please log in to like, share and comment!
Rohit More added blog Other
2026-06-12 10:27:56 -

Adalimumab Biosimilar Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032
According to the latest report published by Data Bridge Market Research, the Adalimumab Biosimilar Market Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30 million in 2022, is expected to reach USD 3431.48 million by 2030, at a CAGR of 24.4% during the forecast period 2023 to 2030. The large scale Adalimumab Biosimilar Marketing report...

0 Comments 0 Shares 121 Views 0 Reviews

Please log in to like, share and comment!
Rohit More added blog Other
2026-07-23 11:47:27 -

Immunoglobulins Market Expands with Growing Demand for Advanced Plasma-Derived Therapies and Immune Support Treatments
According to the latest report published by Data Bridge Market Research, the Immunoglobulins Market Global immunoglobulins market size was valued at USD 16.06 billion in 2024 and is projected to reach USD 27.69 billion by 2032, with a CAGR of 7.05% during the forecast period of 2025 to 2032. The large scale Immunoglobulins Market report is produced with the several decisive...

3

1 Comments 0 Shares 54 Views 0 Reviews

Please log in to like, share and comment!
Rohit More added blog Other
2026-06-17 05:30:53 -

Janus Kinase (JAK) Inhibitor Drugs Market Advances with Expanding Use of Targeted Therapies for Autoimmune and Inflammatory Disorders
According to the latest report published by Data Bridge Market Research, the Janus Kinases (JAKs) Inhibitor Drugs Market Data Bridge Market Research analyses that the Janus kinases (JAKs) inhibitor drugs market, which is USD 2.45 billion in 2022, is expected to reach USD 5.11 billion by 2030, at a CAGR of 9.6% during the forecast period 2023 to 2030 Global Janus Kinases (JAKs)...

0 Comments 0 Shares 64 Views 0 Reviews

Please log in to like, share and comment!
Rohit More added blog Other
2026-06-12 10:48:38 -

Janus Kinase (JAK) Inhibitor Drugs Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032
According to the latest report published by Data Bridge Market Research, the Janus Kinases (JAKs) Inhibitor Drugs Market Data Bridge Market Research analyses that the Janus kinases (JAKs) inhibitor drugs market, which is USD 2.45 billion in 2022, is expected to reach USD 5.11 billion by 2030, at a CAGR of 9.6% during the forecast period 2023 to 2030. To impart a supreme quality to...

0 Comments 0 Shares 102 Views 0 Reviews

Please log in to like, share and comment!